An audit of compliance with NICE guidelines for use of rituximab as first line maintenance treatment of follicular non-Hodgkin's lymphoma, in line with East Midlands Guidelines

被引：0
|
作者：
Attwood, C. [1 ]
Boden, A. [1 ]
Fox, C. [1 ]
Richardson, F. [1 ]
McMillan, A. [1 ]
Haynes, A. [1 ]
机构：
[1] Nottingham Univ Hosp NHS Trust, Dept Haematol, Nottingham, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2013年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
139
引用
收藏
页码：55 / 56
页数：2
相关论文
共 50 条
  • [1] Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin's Lymphoma A NICE Single Technology Appraisal
    Greenhalgh, Janette
    Bagust, Adrian
    Boland, Angela
    Blundell, Michaela
    Oyee, James
    Beale, Sophie
    Dundar, Yenal
    Hockenhull, Juliet
    Proudlove, Chris
    Chu, Patrick
    PHARMACOECONOMICS, 2013, 31 (05) : 403 - 413
  • [2] Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin’s LymphomaA NICE Single Technology Appraisal
    Janette Greenhalgh
    Adrian Bagust
    Angela Boland
    Michaela Blundell
    James Oyee
    Sophie Beale
    Yenal Dundar
    Juliet Hockenhull
    Chris Proudlove
    Patrick Chu
    PharmacoEconomics, 2013, 31 : 403 - 413
  • [3] First-line and maintenance treatment with rituximab for patients with indolent non-Hodgkin's lymphoma
    Hainsworth, JD
    SEMINARS IN ONCOLOGY, 2003, 30 (01) : 9 - 15
  • [4] Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma
    Dundar, Y.
    Bagust, A.
    Hounsome, J.
    McLeod, C.
    Boland, A.
    Davis, H.
    Walley, T.
    Dickson, R.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 23 - 28
  • [5] SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma
    M. Provencio Pulla
    J. Alfaro Lizaso
    L. de la Cruz Merino
    J. Gumá i Padró
    C. Quero Blanco
    J. Gómez Codina
    M. Llanos Muñoz
    N. Martinez Banaclocha
    D. Rodriguez Abreu
    A. Rueda Domínguez
    Clinical and Translational Oncology, 2015, 17 : 1014 - 1019
  • [6] SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma
    Delvys Rodríguez-Abreu
    Marta Llanos Muñoz
    Mariano Provencio Pulla
    Antonio Rueda Domínguez
    Dolores Isla Casado
    Clinical and Translational Oncology, 2010, 12 : 760 - 764
  • [7] SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma
    Provencio Pulla, M.
    Alfaro Lizaso, J.
    de la Cruz-Merino, Luis
    Guma i Padro, J.
    Quero Blanco, C.
    Gomez Codina, J.
    Llanos Munoz, M.
    Martinez Banaclocha, N.
    Rodriguez Abreu, D.
    Rueda Dominguez, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12): : 1014 - 1019
  • [8] SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma
    Rodriguez-Abreu, Delvys
    Llanos Munoz, Marta
    Provencio Pulla, Mariano
    Rueda Dominguez, Antonio
    Isla Casado, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (11): : 760 - 764
  • [9] Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma
    Hainsworth, JD
    Litchy, S
    Burris, HA
    Scullin, DC
    Corso, SW
    Yardley, DA
    Morrissey, L
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) : 4261 - 4267
  • [10] Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular non-Hodgkin's lymphoma in Sweden
    Kasteng, F.
    Erlanson, M.
    Hagberg, H.
    Kimby, E.
    Relander, T.
    Lunckvist, J.
    VALUE IN HEALTH, 2007, 10 (06) : A331 - A331
12345